‘Build back better’ cannot mean longer waiting times for changeGlobal Blood Therapeutics (GBT) UK general manager Nigel Nicholls discusses the impact of COVID-19 for sickle cell patients Share X‘Build back better’ cannot mean longer waiting times for changehttps://pharmaphorum.com/patients/covid-sickle-cell-nhs-impact/
